Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The antiparasitic agent moxidectin is under development for the treatment of onchocerciasis. As the first‐in‐human study of moxidectin used a liquid formulation but other trials used tablets, a study was performed to determine the relative bioavailability of the 2 formulations and to gain more information about the pharmacokinetics of moxidectin. Fifty‐eight healthy male participants were randomized to receive open‐label moxidectin (10 mg) as a tablet (n = 29) or liquid (n = 29) formulation. The mean ± SD pharmacokinetic parameters observed following administration of the tablet were peak concentration (C max) 67.1 ± 27.4 ng/mL, time to peak concentration (t max) 3.2 ± 1.4 hours, area under the concentration time curve (AUC) 4403 ± 2360 ng·h/mL, apparent volume of distribution 3635 ± 1720 L, oral clearance 2.83 ± 1.25 L/h, and elimination half‐life 1032 ± 502 hours. The C max and AUC observed following administration of the liquid formulation were 28.6% and 28.8% higher, respectively, and t max 0.9 hours shorter compared with tablets. No serious adverse events (AEs) were observed. The most commonly reported AEs were headache, infection, diarrhea, asthenia, myalgia, and dizziness during the inpatient phase and flu syndrome, headache, and infection during the 6‐month outpatient phase. There was no difference in reporting of these AEs between formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Cited by
Opoku, N. O., Bakajika, D. K., Kanza, E. M., Howard, H., Mambandu, G. L., Nyathirombo, A., Nigo, M. M., Kasonia, K., Masembe, S. L., Mumbere, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32844-1 · Cited by 304
A Review of Scabies: An Infestation More than Skin Deep
Chandler, D. J., & Fuller, L. C. (2019) · Dermatology · doi:10.1159/000495290 · Cited by 259
Moxidectin: an oral treatment for human onchocerciasis
Milton, P., Hamley, J. I. D., Walker, M., & Basáñez, M.-G. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792772 · Cited by 211
Drug Combinations Against Soil-Transmitted Helminth Infections
(2019) · Advances in Parasitology · doi:10.1016/bs.apar.2018.08.002 · Cited by 92
Metadata
- Authors
- Korth‐Bradley, J. M., Parks, V., Patat, A., Matschke, K., Mayer, P., & Fleckenstein, L.
- Venue
- Clinical Pharmacology in Drug Development
- Publisher
- Wiley
- Published
- 2012-01
- Volume
- 1
- Issue
- 1
- Pages
- 32-37
- ISSN
- 2160-763X (ISSN-L)
- 2160-7648
- OpenAlex
- W2050587086
- Cited by
- 41
- References
- 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin. https://app.cochat.ai/papers/10.1177/2160763x11432508
- The paper
- Korth‐Bradley, J. M., Parks, V., Patat, A., Matschke, K., Mayer, P., & Fleckenstein, L. (2012). Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin. Clinical Pharmacology in Drug Development. https://doi.org/10.1177/2160763x11432508
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.